A senior source familiar with the matter said that AstraZeneca and Bristol-Myers Squibb “never had a deal negotiation from beginning to end.”

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.